search
Back to results

Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses

Primary Purpose

Myopia

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Methafilcon A IV
Ocufilcon B
Omafilcon A
Sponsored by
Coopervision, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Myopia

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • They are of aged 18-40 and have capacity to volunteer.
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They agree not to participate in other clinical research for the duration of this study.
  • They have a contact lens spherical prescription between -1.00 to - 6.00D (inclusive)
  • They have a spectacle cylindrical correction of -0.75D or less in each eye (based on the ocular refraction).
  • They can attain at least 0.10 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range.
  • They currently use soft contact lenses or have done so in the previous six months.

Exclusion Criteria:

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They have had cataract surgery.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or lactating.
  • They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  • They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Sites / Locations

  • Eurolens Research - The University of Manchester

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

Methafilcon A IV

Ocufilcon B

Omafilcon A

Arm Description

Subjects are randomized to wear Methafilcon A IV for 1 hour during the cross over study.

Subjects are randomized to wear Ocufilcon B for 1 hour during the cross over study.

Subjects are randomized to wear Omafilcon A for 1 hour during the cross over study.

Outcomes

Primary Outcome Measures

Visual Acuity Using logMAR
Assessment of visual performance using the Bailey-Lovie logMAR visual acuity test chart and procedures for carrying out an over-refraction
Lens Fit - Horizontal Centration
Assessment of horizontal centration of lens on eye
Lens Fit - Vertical Centration
Assessment of vertical centration of lens on eye
Lens Fit - Corneal Coverage of Lens
Assessment of corneal coverage of lens on eye
Lens Fit - Movement of Lens
Assessment of movement of lens on eye

Secondary Outcome Measures

Full Information

First Posted
July 27, 2017
Last Updated
August 27, 2019
Sponsor
Coopervision, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT03235115
Brief Title
Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses
Official Title
Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses
Study Type
Interventional

2. Study Status

Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
June 23, 2017 (Actual)
Primary Completion Date
September 22, 2017 (Actual)
Study Completion Date
September 22, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Coopervision, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study aims to compare the short-term clinical performance of the three contact lenses (Methafilcon A IV, Ocufilcon B 1-day and Omafilcon A 1-day daily disposable).
Detailed Description
This will be a randomized, double-masked, crossover, bilateral non-dispensing study, controlled by cross-comparison. Forty subjects will wear each lens brand for approximately one hour, on three separate study days in random order. Lenses will only be worn during study visits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myopia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Methafilcon A IV
Arm Type
Active Comparator
Arm Description
Subjects are randomized to wear Methafilcon A IV for 1 hour during the cross over study.
Arm Title
Ocufilcon B
Arm Type
Active Comparator
Arm Description
Subjects are randomized to wear Ocufilcon B for 1 hour during the cross over study.
Arm Title
Omafilcon A
Arm Type
Active Comparator
Arm Description
Subjects are randomized to wear Omafilcon A for 1 hour during the cross over study.
Intervention Type
Device
Intervention Name(s)
Methafilcon A IV
Intervention Description
Contact Lens
Intervention Type
Device
Intervention Name(s)
Ocufilcon B
Intervention Description
Contact Lens
Intervention Type
Device
Intervention Name(s)
Omafilcon A
Intervention Description
Contact Lens
Primary Outcome Measure Information:
Title
Visual Acuity Using logMAR
Description
Assessment of visual performance using the Bailey-Lovie logMAR visual acuity test chart and procedures for carrying out an over-refraction
Time Frame
Dispense and follow-up, approximately one hour (1hr) of lens wear for each lens type worn
Title
Lens Fit - Horizontal Centration
Description
Assessment of horizontal centration of lens on eye
Time Frame
Dispense and follow-up, approximately one hour (1hr) of lens wear for each lens type worn
Title
Lens Fit - Vertical Centration
Description
Assessment of vertical centration of lens on eye
Time Frame
Dispense and follow-up, approximately one hour (1hr) of lens wear for each lens type worn
Title
Lens Fit - Corneal Coverage of Lens
Description
Assessment of corneal coverage of lens on eye
Time Frame
Dispense and follow-up, approximately one hour (1hr) of lens wear for each lens type worn
Title
Lens Fit - Movement of Lens
Description
Assessment of movement of lens on eye
Time Frame
Dispense and follow-up, approximately one hour (1hr) of lens wear for each lens type worn

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: They are of aged 18-40 and have capacity to volunteer. They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent. They are willing and able to follow the protocol. They agree not to participate in other clinical research for the duration of this study. They have a contact lens spherical prescription between -1.00 to - 6.00D (inclusive) They have a spectacle cylindrical correction of -0.75D or less in each eye (based on the ocular refraction). They can attain at least 0.10 logMAR distance high contrast visual acuity in each eye with the study lenses within the available power range. They currently use soft contact lenses or have done so in the previous six months. Exclusion Criteria: They have an ocular disorder which would normally contra-indicate contact lens wear. They have a systemic disorder which would normally contra-indicate contact lens wear. They are using any topical medication such as eye drops or ointment. They have had cataract surgery. They have had corneal refractive surgery. They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus. They are pregnant or lactating. They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction. They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Facility Information:
Facility Name
Eurolens Research - The University of Manchester
City
Manchester
ZIP/Postal Code
M13 9PL
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Fitting Evaluation of Hydrogel and Silicone Hydrogel Spherical Contact Lenses

We'll reach out to this number within 24 hrs